Advertisement

PentaVision

Ophthalmology Management

Article | 2025 ASCRS Annual Meeting

Violet Light-Filtering IOL Implants for Glaucoma Patients

Zarmeena Vendal, MD, shares insights from her presentation at the 2025 ASCRS meeting.

Ophthalmology Management April 28, 2025
5 Key Takeaways

  • 1

    Dr. Zarmeena Vendal presented a study on violet light-filtering IOLs for glaucoma patients at the 2025 ASCRS Annual Meeting.

  • 2

    The study focused on the Johnson & Johnson Tecnis Symfony OptiBlue IOL, which filters violet light to improve contrast and reduce nighttime vision issues.

  • 3

    Eighty percent of patients achieved 20/20 vision for distance, and 100% had 20/30 or better vision at various distances post-implantation.

  • 4

    Approximately 80% of patients reported little to no need for glasses, with 95% spectacle independence for distance and 87% for intermediate tasks.

  • 5

    Despite some experiencing nighttime dysphotopsias, 80% of those affected were not bothered by them, indicating overall patient satisfaction.